Evolv restatements eliminate ‘major overhang,’ says Northland

Northland analyst Michael Latimore notes that Evolv (EVLV) announced the filing of its 10K and restatements, which “eliminates a major overhang on the stock.” Q4 recurring revenue was in line with the firm’s estimate, adds the analyst, who expects Evolv to host a Q1 earnings call in May. The filing will allow management to focus more attention on growth now, according to the firm, which keeps a Market Perform rating on Evolv shares.